D. Layla Al Aali
Discovering medicines enter a transformative era with a deeper understanding of humans
A clinical pharmacist and member of the Friends of Health Association, Dr. Layla Al -Alia. Medicine is witnessing this year 2025 a noticeable transformation towards accurate and personal medicine, with innovations in multiple therapeutic fields that heralds the redefinition of how to treat diseases, while the world of discovery of medicines enter a transformative era, driven by advanced science and digital techniques and a deeper understanding of human biology.
Dr. The highest is that “one of the most leading developments is the use of genes -based genetics processing treatments, as these drugs, which were previously a concept that is limited to laboratories, is now entering into clinical application, including treatments that target sickle cell anemia and beta -Thalassimia, as it provides potential treatments by correcting genetic mutations at the level of DNA, which represents an important step forward in treating disorders Genetic.
According to Dr. Layla Al -Aali, “Researchers develop treatments based on a wide range of diseases, including cancer (, autoimmune diseases, and rare genetic disorders. These drugs can direct the body to produce treatment proteins, providing faster and more adaptive response to the disease.”
Regarding oncology, Dr. The highest is that “radiological pharmaceutical preparations in the directed are gaining increasing interest in their accuracy in the delivery of radioactive loads directly to the cancerous cells, which reduces the damage of healthy tissues, while the protection represents a new category of medicines that remove pathogens that cause pathogens instead of simply inhibiting them. This has opened new horizons in treating cancer types that were previously considered other than Treatable. ”
According to a member of the Friends of Health Association: “Infectious diseases research is still a priority, while seeking to develop broad -spectrum anti -viral anti -anti -protective anti -protection, and tested new drugs that exist on nanoparticles, which are smaller and more stable than traditional antibodies, to test their capabilities in both infectious diseases and autoimmune diseases.”
And I struck Dr. Higher is an example of progress in the field of degenerative neurological diseases, especially Alzheimer’s disease “as it targets medications such as Likanimab and Donnimab Luja Beta amyloid, with the aim of slowing the cognitive deterioration. Although they are not healing treatments, they represent the first real average might of the disease for decades.”
And Dr. High Technology also reformulates the process of delivery of medications. Digital pimples – which are smart capsules that monitor patients ’commitment to treatment, and send data to health care providers. This innovation aims to improve the results in managing chronic diseases by ensuring patients’ consumption of medicines properly and on time.
According to Dr. Higher: “Human microbium is another interesting field. New treatments aim to restore the bacteria of the intestine or adjust them to improve health results in cases ranging from metabolic disorders to inflammatory diseases.”
She concluded by saying: “These various innovations show a broader shift in the pharmaceutical scene. Instead of following a single approach that suits everyone, the development of drugs is directed to specially designed treatments that take into account genetic and environmental factors and lifestyle. As the intersection of science and technology continues, the promise has become safer, effective and personal, realistic, realistic, which re -defining the future of medicine.”
